Warning: The NCBI web site requires JavaScript to function. more...
An official website of the United States government
The .gov means it's official. Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you're on a federal government site.
The site is secure. The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.
LOC100507652 - Tamoxifen effect on SRC-1-deficient endocrine-resistant breast cancer cell line LY2
GEO DataSets Profile neighbors
Tamoxifen effect on SRC-1-deficient endocrine-resistant breast cancer cell line LY2
IL6R - Tamoxifen effect on SRC-1-deficient endocrine-resistant breast cancer cell line LY2
GEO DataSets Gene Profile neighbors Chromosome neighbors Homologene neighbors
ERGIC3 - Tamoxifen effect on SRC-1-deficient endocrine-resistant breast cancer cell line LY2
IL17A - Tamoxifen effect on SRC-1-deficient endocrine-resistant breast cancer cell line LY2
PRSS12 - Tamoxifen effect on SRC-1-deficient endocrine-resistant breast cancer cell line LY2
LINC00174 - Tamoxifen effect on SRC-1-deficient endocrine-resistant breast cancer cell line LY2
GEO DataSets Gene Profile neighbors Chromosome neighbors
PI15 - Tamoxifen effect on SRC-1-deficient endocrine-resistant breast cancer cell line LY2
THBS2 - Tamoxifen effect on SRC-1-deficient endocrine-resistant breast cancer cell line LY2
CADM4 - Tamoxifen effect on SRC-1-deficient endocrine-resistant breast cancer cell line LY2
RAB3C - Tamoxifen effect on SRC-1-deficient endocrine-resistant breast cancer cell line LY2
KLF9 - Tamoxifen effect on SRC-1-deficient endocrine-resistant breast cancer cell line LY2
STH - Tamoxifen effect on SRC-1-deficient endocrine-resistant breast cancer cell line LY2
DKFZP434K028 - Tamoxifen effect on SRC-1-deficient endocrine-resistant breast cancer cell line LY2
DNAH6 - Tamoxifen effect on SRC-1-deficient endocrine-resistant breast cancer cell line LY2
IKZF1 - Tamoxifen effect on SRC-1-deficient endocrine-resistant breast cancer cell line LY2
ZNF175 - Tamoxifen effect on SRC-1-deficient endocrine-resistant breast cancer cell line LY2
PHF21A - Tamoxifen effect on SRC-1-deficient endocrine-resistant breast cancer cell line LY2
Filters: Manage Filters
Your browsing activity is empty.
Activity recording is turned off.
Turn recording back on